⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Sarcopenia as a Multi-Organ Metabolic-Inflammatory (GLAM) Axis
Current understanding
A proposed synthesis framework in which sarcopenia anchors a gut–liver–adipose–muscle (GLAM) crosstalk network where insulin resistance and shared AMPK/mTOR, mtROS–p53, and acetyl-CoA/HAT modules integrate inflammaging, nutrient sensing, mitochondrial stress, and epigenetic drift across organs [expert-opinion]. Positioned as a conceptual scaffold rather than a validated causal model — no primary lifespan or human-outcome data attached to the framework itself; mechanistic modules invoked are individually supported at animal-model or mechanism-plausible tiers.
Evidence log
- 2026-09-28 — Autophagy Flux Is Remodeled Sex‐ and Cell Type‐Specifically During Human Aging, and Is Linked to Reduced Physical Function in Older Adults: cross-connection with autophagy: Human association between autophagy flux and reduced physical function links cell-type-specific autophagy decline to the sarcopenia/physical-frailty axis at a measurement (not inference) level. (novelty: 3)
- 2026-10-04 — Single-Nucleus Atlas of Spinal Sarcopenia Patients Reveals Disruption of Quiescent and Regenerative Satellite Cell Niches in Fatty-Infiltrated Muscle.: cross-connection with fap-adipogenesis-muscle-aging: Lipogenic GPC3+ FAPs provide a cellular substrate for the intramuscular adipogenesis component of the GLAM sarcopenia framework. (novelty: 4)
- 2026-09-29 — Infectious diseases and sarcopenia-related phenotypes: A phenome-wide Mendelian randomization study with exploratory proteomic analysis.: cross-connection with inflammaging: MR evidence that genetic liability to specific infections (tonsillitis, TB sequelae, postzoster neuralgia) perturbs appendicular lean mass but not grip strength places the infection→inflammaging arm within the GLAM multi-organ sarcopenia framework as a muscle-mass-selective rather than strength-selective input. (novelty: 3)
- 2026-10-01 — A Mendelian randomization study reveals TNF-β as a potential protective factor against sarcopenia.: cross-connection with inflammaging: MR evidence that circulating TNF-β is causally protective against multiple sarcopenia traits links the inflammaging substrate to the sarcopenia GLAM axis at the level of specific cytokine direction, not just aggregate inflammatory tone. (novelty: 3)
- 2026-09-30 — Sex- and age-specific patterns in bone, muscle, and fat across adulthood and their relation to osteosarcopenic adiposity phenotype: a cross-sectional study.: cross-connection with menopause-estrogen-decline: Osteosarcopenic adiposity phenotype in midlife women links the menopausal sex-steroid inflection to the combined bone-muscle-fat deterioration captured by the GLAM sarcopenia frame. (novelty: 3)
- 2026-09-25 — An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.: cross-connection with adipose-thermogenesis-beiging: Preclinical combo of adipose-directed ZFP423 ASO + semaglutide preserves lean mass during weight loss, linking beige-fat induction to the muscle-sparing side of the GLAM metabolic-inflammatory axis. (novelty: 4)
- 2026-05-15 — Jintiange ameliorates age-related sarcopenia by inhibiting the cGAS-STING signaling pathway via maintaining mitochondrial homeostasis.: cross-connection with cgas-sting-dna-sensing: mtDNA leakage engaging cGAS–STING/NF-κB in aged skeletal muscle is nominated as a proximal inflammatory driver of sarcopenia, extending the DNA-sensing axis into the muscle-anchored metabolic-inflammatory (GLAM) framework. (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: cross-connection with gut-microbiota-bile-acid-fxr-fgf15-muscle: Human serum bile-acid species (3β-HDCA, GLCA, TLCA) associate with primary sarcopenia, providing a metabolite-level human readout of the gut–liver–muscle arm of the GLAM framework. (novelty: 3)
- 2026-08-24 — Form and function of actin impacts actin health and aging.: cross-connection with actin-cytoskeleton-aging: Human ACTN3 polymorphism–gait-speed decline signal links actin cytoskeletal biology to the sarcopenia/functional-decline axis, offering a genetic tie between a cytoskeletal component and a clinical aging-muscle phenotype. (novelty: 3)
- 2026-09-16 — Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction.: cross-connection with brain-muscle-axis: Adds a brain-iron/BBB arm to the multi-organ GLAM view of sarcopenia, complementing the metabolic-inflammatory drivers with a CNS-vascular input. (novelty: 3)
- 2026-09-22 — Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.: cross-connection with gut-microbiota-bone-axis: Extends the GLAM (gut–liver–adipose–muscle) inflammatory framework to include bone/joint tissues as co-regulated targets of gut-derived LPS and SCFA signaling under diet–exercise modulation. (novelty: 3)
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: cross-connection with ferroptosis: Selenium deficiency links GPX4-dependent ferroptosis to the sarcopenia GLAM axis, adding a lipid-peroxidation cell-death route to the multi-organ metabolic-inflammatory framing of muscle aging. (novelty: 3)
- 2026-09-18 — Imeglimin provides dual hepatic and skeletal muscle protection in experimental MASH-associated sarcopenia.: cross-connection with mitochondrial-dysfunction: Imeglimin’s dual hepatic + skeletal-muscle protection in MASH-associated sarcopenia operationalizes the GLAM axis at the drug level: a single mitochondrial modulator engages the liver–muscle arm of the metabolic-inflammatory sarcopenia framework. (novelty: 3)
- 2026-08-14 — Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.: cross-connection with tweak-fn14-muscle-aging: TWEAK/Fn14–AMPK–p38 links a specific TNF-family cytokine mechanism to the GLAM framework’s metabolic-inflammatory picture of sarcopenia, providing a discrete molecular substrate for the AMPK/mTOR + inflammatory modules the review names. (novelty: 3)
- 2026-08-10 — HB05P on Muscle Health: cross-connection with gut-microbiota-healthspan: HB05P pilot operationalizes the gut-node contribution to the GLAM sarcopenia framework by testing a pasteurized-Akkermansia postbiotic against isokinetic muscle strength in older adults with sarcopenia. (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: cross-connection with gut-microbiota-healthspan: Planned young-donor FMT trial explicitly targets sarcopenia and muscle function as primary healthspan endpoints, operationalizing the gut node of the GLAM metabolic-inflammatory axis as a directly modifiable input to muscle aging. (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: cross-connection with sex-dimorphic-sarcopenia-hormones: GLAM framework anchors multi-organ metabolic-inflammatory aging on sarcopenia; the sex-dimorphic apelin/insulin/oxytocin page adds hormonal patterning of that same muscle-anchored axis. (novelty: 3)
Open questions
Related
Contributing findings
The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.
13-apr-2026
novelty 3
per-area 3
introduces